CenturyCom, I'm unsure of the point that you are trying to make.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

milestone

Rank: President [?]

Points: 18650 [?]

Votes: 158 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

CenturyCom, I'm unsure of the point that you are trying to make.

in response to

CenturyCom, with equal due respect

CenturyCom

posted on Nov 16, 2007 02:47AM

During 1 quarter 263,983 shares were sold by probably 1 institutional investor, that still left 126 institutions holding 80% of the float. One day, hopefully, PTSC will be in a similar position.

I was merely giving you one example to counter your statement that, "Institutions hate R/S" - it's not the R/S that dissuades institutional investment but Company fundamentals. Any decent Company going the R/S route will always attract institutions.

Any notion that broaching the subject is either FUD or bashing is totally specious.